Brain Imaging Technology to Examine the Effects of Meditation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00082160|
Recruitment Status : Completed
First Posted : May 4, 2004
Last Update Posted : August 4, 2006
|Condition or disease||Intervention/treatment|
|Healthy||Behavioral: Meditation Procedure: Functional Magnetic Resonance Imaging|
Meditation and relaxation-based interventions are becoming more widely accepted in clinical settings because of their low cost, low risk, and proven effectiveness as a complementary intervention in a wide range of diseases. Despite the success and growing use of relaxation-based treatments, few studies have addressed the basic mechanism by which these treatments work. This study will use functional magnetic resonance imaging (fMRI) to define the brain mechanisms underlying the meditative state, to differentiate this state from other states, and to determine how meditation-induced brain changes affect autonomic function.
Participants in this study will have an fMRI brain scan. Brain activity, breathing rate, and heart rate will be measured while the participant engages in three different activities: lying quietly, meditating, and mentally generating numbers.
|Study Type :||Observational|
|Enrollment :||60 participants|
|Observational Model:||Defined Population|
|Observational Model:||Natural History|
|Official Title:||fMRI Investigation of Meditation|
|Study Start Date :||July 2001|
|Study Completion Date :||June 2005|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00082160
|United States, Massachusetts|
|Massachusetts General Hospital|
|Boston, Massachusetts, United States, 02129|
|Principal Investigator:||Sara Lazar, PhD||Massachusetts General Hospital Department of Psychiatry|